Cargando…
A rare case of imatinib-induced erythroderma
Imatinib, a specific tyrosine kinase inhibitor is a newer anticancer agent, which has shown excellent efficacy in managing chronic myeloid leukemia. It is generally well tolerated with few side effects. Most commonly reported adverse events are maculopapular eruptions and periorbital edema. Severe a...
Autores principales: | Verma, Rajesh, Vasudevan, Biju, Pragasam, Vijendran, Neema, Shekhar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847261/ https://www.ncbi.nlm.nih.gov/pubmed/24347779 http://dx.doi.org/10.4103/0253-7613.121386 |
Ejemplares similares
-
First reported case of tenofovir-induced photoallergic reaction
por: Verma, Rajesh, et al.
Publicado: (2012) -
A rare case of isoniazid-induced erythroderma
por: Garg, Yashika, et al.
Publicado: (2015) -
Allopurinol induced erythroderma
por: Sharma, Geeta, et al.
Publicado: (2013) -
Hydroxychloroquine-induced erythroderma
por: Pai, Sunil B., et al.
Publicado: (2017) -
Congenital ichthyosiform erythroderma: A rare neonatal dermatoses responding to acitretin
por: Patro, Nibedita, et al.
Publicado: (2019)